Top Markets
#1 Islamic Coin Islamic Coin +152.63%
#2 Bitway Bitway +45.44%
#3 Starpower Starpower +37.89%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +37.74%
#5 Pons Pons +33.63%
#6 aelf aelf +26.00%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.55%
#8 SkyAI SkyAI +18.96%
#9 Ocean Protocol Ocean Protocol +16.67%
#10 Decred Decred +14.08%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Modalis Therapeutics Corporation Modalis Therapeutics Corporation

Modalis Therapeutics Corporation

4883
Classifica tra le azioni #29675
Modalis Therapeutics Corporation focuses on discovering and developing... Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery methods for the central nervous system (CNS), particularly for CNS-related disorders. Founded in 2016, the company was initially known as EdiGENE Corporation before changing its name to Modalis Therapeutics Corporation in August 2019. Its operations are based in Tokyo, Japan.
Prezzo delle azioni
$0.20877985
Capitalizzazione di mercato
$20.11M
Variazione (1 giorno)
-3.03%
Variazione (1 anno)
-66.13%
Paese
JP
Scambia Modalis Therapeutics Corporation (4883)

Categoria

Healthcare
Rapporto P/S per Modalis Therapeutics Corporation (4883)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Modalis Therapeutics Corporation, il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Modalis Therapeutics Corporation da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR